SuperworthWerewolf Therapeutics shares outstanding HOWL
Diluted shares outstanding, averaged over each quarter, from 2020.
- Latest quarter, to Jun 30, 2026
- 48.6M
- On a year earlier
- +8.0%
- more shares
Werewolf Therapeutics had 48.6M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 8.0% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 48.4M | +9% |
| FY2024 | 44.5M | +22% |
| FY2023 | 36.6M | +19% |
| FY2022 | 30.7M | +13% |
| FY2021 | 27.3M | +2263% |
| FY2020 | 1.2M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 48.6M | +8% | |
| Q1 FY26 | 49.4M | +10% | |
| Q4 FY25 | 48.4M | +9% | |
| Q3 FY25 | 45.8M | +5% | |
| Q2 FY25 | 45M | +2% | |
| Q1 FY25 | 44.8M | +8% | |
| Q4 FY24 | 44.5M | +22% | |
| Q3 FY24 | 43.7M | +23% | |
| Q2 FY24 | 44M | +24% | |
| Q1 FY24 | 41.6M | +20% | |
| Q4 FY23 | 36.6M | +19% | |
| Q3 FY23 | 35.7M | +20% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Werewolf Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.